Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer

被引:132
|
作者
Ko, Naomi Y. [1 ,2 ]
Hong, Susan [3 ]
Winn, Robert A. [4 ]
Calip, Gregory S. [3 ,5 ]
机构
[1] Boston Univ, Hematol & Med Oncol, Sch Med, 820 Harrison Ave,FGH Bldg,First Floor, Boston, MA 02118 USA
[2] Boston Med Ctr, Boston, MA USA
[3] Univ Illinois, Canc Prevent & Control Program, Canc Ctr, Chicago, IL USA
[4] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA
[5] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Epidemiol Program, 1124 Columbia St, Seattle, WA 98104 USA
基金
美国国家卫生研究院;
关键词
QUALITY-OF-LIFE; HEALTH-INSURANCE; ADJUVANT CHEMOTHERAPY; LONG-TERM; MEDIATION ANALYSIS; SURVIVAL; STATISTICS; MORTALITY; DIAGNOSIS; COSTS;
D O I
10.1001/jamaoncol.2019.5672
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Importance Compared with non-Hispanic white women, racial/ethnic minority women receive a diagnosis of breast cancer at a more advanced stage and have higher morbidity and mortality with breast cancer diagnosis. Access to care with adequate insurance may be associated with earlier diagnosis, expedited treatment, and improved prognosis. Objective To examine the extent to which insurance is associated with access to timely breast cancer diagnosis and breast cancer stage differences among a large, diverse population of US patients with breast cancer. Design, Setting, and Participants This retrospective, cross-sectional population-based study used data from the Surveillance, Epidemiology, and End Results Program on 177 075 women aged 40 to 64 years who received a diagnosis of stage I to III breast cancer between January 1, 2010, and December 31, 2016. Statistical analysis was performed from August 1, 2017, to October 1, 2019. Main Outcomes and Measures The primary outcome was the risk of having a more advanced stage of breast cancer at diagnosis (ie, stage III vs stages I and II). Mediation analyses were conducted to determine associations of race/ethnicity and proportion of observed differences mediated by health insurance status with earlier stage of diagnosis. Results A total of 177 075 women (mean [SD] age, 53.5 [6.8] years; 148 124 insured and 28 951 uninsured or receiving Medicaid) were included in the study. A higher proportion of women either receiving Medicaid or who were uninsured received a diagnosis of locally advanced breast cancer (stage III) compared with women with health insurance (20% vs 11%). In multivariable models, non-Hispanic black (odds ratio [OR], 1.46 [95% CI, 1.40-1.53]), American Indian or Alaskan Native (OR, 1.31 [95% CI, 1.07-1.61]) and Hispanic (OR, 1.35 [95% CI, 1.30-1.42]) women had higher odds of receiving a diagnosis of locally advanced disease (stage III) compared with non-Hispanic white women. When adjusting for health insurance and other socioeconomic factors, associations between race/ethnicity and risk of locally advanced breast cancer were attenuated (non-Hispanic black: OR, 1.29 [95% CI, 1.23-1.35]; American Indian or Alaskan Native: OR, 1.11 [95% CI, 0.91-1.35]; Hispanic: OR, 1.17 [95% CI, 1.12-1.22]). Nearly half (45%-47%) of racial differences in the risk of locally advanced disease were mediated by health insurance. Conclusions and Relevance This study's findings suggest that nearly half of the observed racial/ethnic disparities in higher stage at breast cancer diagnosis are mediated by health insurance coverage.
引用
收藏
页码:385 / 392
页数:8
相关论文
共 50 条
  • [21] Disparities in Early-Stage Breast Cancer and Survival-Letter
    Bazan, Jose G.
    Obeng-Gyasi, Samilia
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (09) : 1867 - 1867
  • [22] Socioeconomic Disparities in Neoadjuvant Chemotherapy for Early-Stage Breast Cancer
    McGuire, Kandace
    Reissis, Yannis
    Karim, Tahia
    Wolfe, Luke
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 421 - 421
  • [23] Socioeconomic Disparities in Neoadjuvant Chemotherapy for Early-Stage Breast Cancer
    Reissis, Yannis
    Wolfe, Luke
    Karim, Tahia
    Mosquera, Catalina
    McGuire, Kandace
    AMERICAN SURGEON, 2023, 89 (04) : 589 - 595
  • [24] Disparities in Early-Stage Breast Cancer and Survival-Reply
    Primm, Kristin M.
    Zhao, Hui
    Hernandez, Daphne C.
    Chang, Shine
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (09) : 1868 - 1868
  • [25] Reducing Racial Disparities in Treatment for Early-Stage Lung Cancer With a Multimodal Intervention
    Manning, M.
    Cykert, S.
    Eng, E.
    Yee, M. K.
    Robertson, L.
    Hardy, C.
    Schaal, J.
    Heron, D. E.
    Jones, N.
    Foley, K.
    Smith, B.
    Alexandra, L.
    Samuel, C.
    Gizlice, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S35 - S35
  • [26] Racial disparities in the use of radical prostatectomy for early-stage prostate cancer.
    Denberg, TD
    Perez-Stable, EJ
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 : 156 - 156
  • [27] Racial and Economic Disparities in Social Support and Symptom Distress among Women Diagnosed with Early-Stage Breast Cancer
    Abujaradeh, Hiba
    Mazanec, Susan
    Sereika, Susan M.
    Brufsky, Adam M.
    Bender, Catherine M.
    Connolly, Mary C.
    Rosenzweig, Margaret Q.
    CANCER RESEARCH, 2023, 83 (05)
  • [28] Household Net Worth, Racial Disparities, and Hormonal Therapy Adherence Among Women With Early-Stage Breast Cancer
    Hershman, Dawn L.
    Tsui, Jennifer
    Wright, Jason D.
    Coromilas, Ellie J.
    Tsai, Wei Yann
    Neugut, Alfred I.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) : 1053 - +
  • [29] Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer
    Zhao, Fangyuan
    Miyashita, Minoru
    Hattori, Masaya
    Yoshimatsu, Toshio
    Howard, Frederick
    Kaneva, Kristiyana
    Jones, Ryan
    Bell, Joshua S. K.
    Fleming, Gini F.
    Jaskowiak, Nora
    Nanda, Rita
    Zheng, Yonglan
    Huo, Dezheng
    Olopade, Olufunmilayo I.
    JAMA NETWORK OPEN, 2023, 6 (03) : E233329
  • [30] A Contemporary Analysis of Racial and Ethnic Disparities in Diagnosis of Early-Stage Breast Cancer and Stage-Specific Survival by Molecular Subtype
    Primm, Kristin M.
    Zhao, Hui
    Hernandez, Daphne C.
    Chang, Shine
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (06) : 1185 - 1194